A RECENT study examined the role of TP53 mutations or deletions in the prognosis of myelodysplastic syndrome (MDS) patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback